Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial compared erlotinib and docetaxel for a type of non small cell lung cancer called squamous cell cancer. It was for people whose cancer had got worse despite having treatment with a platinum chemotherapy drug.
Recruitment start: 14 January 2013
Recruitment end: 31 January 2014
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Yvonne Summers
Biodesix
European Thoracic Oncology Platform (ETOP)
NIHR Clinical Research Network: Cancer
Last reviewed: 5 June 2018
CRUK internal database number: 10665
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
